Emerging Brain Tumor Organoid Models for Studying Tumor Heterogeneity, Microenvironmental Interactions, and Therapeutic Response
Journal of Neurochemistry · 2026-11 · 170 (11)
DOI: 10.1111/jnc.70589 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Neurochemistry, online erschienen am 13.11.2026. Verfasst von Fermisk Saleh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Tumor Microenvironment, Organoids, Brain Neoplasms. Die Arbeit nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Terry Fox Research Institute, CIHR, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Brain tumors are genetically and cellularly heterogeneous and interact extensively with neural, vascular, immune, and extracellular microenvironments that conventional experimental models reproduce incompletely. This review examines how brain tumor organoids are generated, how they have been applied in brain tumor research, and the challenges that must be overcome for broader application. Current approaches differ along two largely independent axes: whether tumor cells are derived directly from patient tissue or generated through defined genetic alterations, and whether the surrounding microenvironment is retained from the source tissue or deliberately reconstructed. We discuss how these models have been used to study genetic drivers of tumor initiation, intratumoral heterogeneity, tumor–microenvironment interactions, mechanisms of invasion, and patient‐specific therapeutic responses and resistance. Across these applications, organoids have provided experimentally tractable systems in which to investigate tumor cell‐state plasticity, tumor–neural interactions, microenvironmental regulation of tumor behavior, and variability in treatment response while preserving features of human disease often lost in conventional systems. At the same time, model establishment remains variable, cultures can diverge during prolonged propagation, and vascular and immune compartments remain incompletely represented. Brain tumor organoids therefore complement rather than replace two‐dimensional culture systems, genetically engineered mouse models, and patient‐derived xenografts. Future progress will depend on rigorous standardization of organoid generation and characterization, together with the selective incorporation of biological and engineering complexity according to the specific experimental or therapeutic question being addressed. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry, University of Toronto, Toronto, Ontario, Canada.
- Sunnybrook Research Institute, Biological Sciences Platform, Toronto, Ontario, Canada.
ORCID-Profile: Fermisk Saleh, Carol Schuurmans
Förderung
- Terry Fox Research Institute
- CIHR
- Canadian Institutes of Health Research
Zitieren
APA
Saleh, F., & Schuurmans, C. (2026). Emerging Brain Tumor Organoid Models for Studying Tumor Heterogeneity, Microenvironmental Interactions, and Therapeutic Response. Journal of Neurochemistry, 170(11). https://doi.org/10.1111/jnc.70589
Vancouver
Saleh F, Schuurmans C. Emerging Brain Tumor Organoid Models for Studying Tumor Heterogeneity, Microenvironmental Interactions, and Therapeutic Response. Journal of Neurochemistry. 2026;170(11). doi:10.1111/jnc.70589
BibTeX
@article{Saleh2026,
author = {Saleh, Fermisk and Schuurmans, Carol},
title = {Emerging Brain Tumor Organoid Models for Studying Tumor Heterogeneity, Microenvironmental Interactions, and Therapeutic Response},
journal = {Journal of Neurochemistry},
year = {2026},
volume = {170},
number = {11},
doi = {10.1111/jnc.70589}
}
EUVIMED